生物医学人工智慧市场：按组件、技术、应用和最终用户划分 - 2025-2030 年全球预测

预计2023年生物医学领域人工智慧市场规模为47亿美元，预计2024年将达57.8亿美元，复合年增长率为24.18%，预计2030年将达214亿美元。

人工智慧（AI）在生物医学领域的应用范围广泛，从药物发现、基因组学、医学影像处理到病患监测和个人化医疗。人工智慧具有快速分析大型资料集、识别复杂模式和预测结果的能力，对于改善决策流程和业务效率至关重要。作为应用，机器学习、自然语言处理和机器人流程自动化等人工智慧技术被用来优化临床试验、提高诊断准确性并加快药物开发过程。最终用途领域包括医疗保健提供者、製药公司、研究机构等。市场成长的主要驱动力是精准医疗需求的不断增长、人工智慧技术的进步以及不断增长的医疗资料。此外，政府支持人工智慧和物联网（IoT）整合的倡议正在加强人工智慧在生物医学应用中的应用。

影响成长的关键因素包括医疗保健支出的增加、有利的法规环境以及科技公司与医疗保健提供者之间的合作。然而，市场扩张面临资料隐私问题、高昂的实施成本以及缺乏熟练的人工智慧和生物医学专家的挑战。儘管存在这些障碍，但开发用于早期疾病检测和监测的人工智慧工具的机会仍然很多，需要创新方法和多学科合作。希望利用这些机会的公司可以透过与学术和研究机构合作来开发人工智慧解决方案来解决未满足的临床需求，从而受益。

创新应着重于整合人工智慧和穿戴式技术，开发用于患者特定预测的综合人工智慧模型，并探索无监督学习技术以有效处理非结构化资料。该市场竞争激烈且发展迅速，成熟的医疗保健营业单位和高科技新兴企业都进行了大量投资。公司必须持续监控监管变化和技术进步，才能在这个动态环境中保持领先地位。透过促进创新和策略合作，企业不仅可以克服当前的限制，还可以抓住新的成长机会。

市场动态：生物医学市场快速发展的人工智慧的关键市场洞察

供需的动态交互作用正在改变生物医学人工智慧市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

• 市场驱动因素
  • 全球生物医学领域数位化与研究的增加
  • 药物发现和开发活动迅速增加
  • 对个人化和客製化医疗的需求不断增长
• 市场限制因素
  • 生物医学领域人工智慧的高成本
• 市场机会
  • 生物医学解决方案中人工智慧的技术进步
  • 生物医学解决方案人工智慧开发的有利投资环境
• 市场挑战
  • 资料隐私和安全问题

波特五力：驾驭生物医学人工智慧市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解外部对生物医学市场人工智慧的影响

外部宏观环境因素对于塑造生物医药市场人工智慧的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解生物医学人工智慧市场竞争格局

对生物医学市场人工智慧的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 生物医学市场人工智慧定位矩阵供应商绩效评估

FPNV定位矩阵是评估生物医学市场人工智慧供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製您在生物医学市场人工智慧的成功之路

对于旨在加强其在全球市场的影响力的公司来说，生物医学市场人工智慧的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

• 市场动态
  • 促进因素
    • 全球生物医学领域的数位化和研究不断增加
    • 药物发现和开发活动迅速增加
    • 对个人化和客製化医疗保健的需求不断增长
  • 抑制因素
    • 人工智慧在生物医学领域的高成本
  • 机会
    • 生物医学解决方案中人工智慧的技术进步
    • 生物医学解决方案人工智慧开发的有利投资环境
  • 任务
    • 资料隐私和安全问题
• 市场区隔分析
  • 类型：基于人工智慧的生物医学软体的大量采用
  • 应用：广泛用于药物发现与开发
  • 最终用户：扩大以人工智慧为基础的生物医学解决方案在製药公司的应用
• 波特五力分析
• PESTEL分析
  • 政治的
  • 经济
  • 社群
  • 技术的
  • 合法地
  • 环境

第六章生物医学领域的人工智慧市场：按组成部分

• 硬体
• 服务
• 软体

第七章生物医学领域的人工智慧市场：依技术分类

• 电脑视觉
• 上下文感知计算
• 机器学习
• 自然语言处理
• 查询方式

第八章生物医学领域的人工智慧市场：按应用分类

• 临床决策支持
• 临床试验协调员和临床实验
• 药物发现与开发
• 基因组学和个人化医疗
• 医学影像和放射诊断

第九章生物医学领域的人工智慧市场：按最终用户划分

• 生技公司
• 医院和诊断中心
• 製药公司
• 调查机构

第10章：美洲生物医学领域的人工智慧市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第十一章 亚太地区生物医学人工智慧市场

• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第十二章：欧洲、中东和非洲生物医学领域的人工智慧市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第十三章竞争格局

• 2023 年市场占有率分析
• FPNV 定位矩阵，2023
• 竞争情境分析
  • Bionl.AI 推出无程式码生物医学研究创新平台
  • 认知 AI 在 BIO 上展示生物医学 GPT
  • NIH 推出 Bridge2AI 计划，扩大人工智慧和行为研究在生物医学中的应用
• 战略分析和建议

公司名单

• AiCure, LLC
• Arterys Inc.
• Aspen Technology Inc
• Atomwise Inc
• Augmedix, Inc.
• Behold.ai Technologies Limited
• BenevolentAI SA
• BioSymetrics Inc.
• BPGbio Inc.
• Butterfly Network, Inc.
• Caption Health, Inc. by GE Healthcare
• Cloud Pharmaceuticals, Inc.
• CloudMedX Inc.
• Corti ApS
• Cyclica Inc
• Deargen Inc
• Deep Genomics Incorporated
• Euretos Services BV
• Exscientia plc
• Google, LLC by Alphabet, Inc.
• Insilico Medicine
• Intel Corporation
• International Business Machines Corporation
• InveniAI LLC
• Isomorphic Labs
• Novo Nordisk A/S
• Sanofi SA
• Turbine Ltd.
• Viseven Europe OU
• XtalPi Inc.

The Artificial Intelligence in Biomedical Market was valued at USD 4.70 billion in 2023, expected to reach USD 5.78 billion in 2024, and is projected to grow at a CAGR of 24.18%, to USD 21.40 billion by 2030.

The scope of artificial intelligence (AI) in the biomedical sector encompasses a wide range of applications from drug discovery, genomics, and medical imaging to patient monitoring and personalized medicine. AI is integral due to its ability to analyze large datasets rapidly, identify complex patterns, and predict outcomes, thereby enhancing decision-making processes and operational efficiencies. In application, AI technologies like machine learning, natural language processing, and robotic process automation are being employed to optimize clinical trials, improve diagnostic accuracy, and accelerate the drug development process. End-use sectors include healthcare providers, pharmaceutical companies, and research institutions. Market growth is chiefly driven by the increasing demand for precision medicine, technological advancements in AI, and a growing volume of healthcare data. Further, government initiatives supporting AI and the Internet of Things (IoT) integration bolster the uptake of AI in biomedical applications.

Key influencing growth factors include increasing healthcare expenditure, favorable regulatory environments, and collaborations between tech companies and healthcare providers. However, market expansion is challenged by concerns over data privacy, high implementation costs, and a shortage of skilled professionals in AI and biomedicine. Despite these hurdles, opportunities abound in the development of AI-powered tools for early disease detection and monitoring, which demand innovative approaches and interdisciplinary collaboration. For businesses aiming to capitalize on these opportunities, targeting AI solutions that address unmet clinical needs and collaborating with academic and research institutions may prove beneficial.

Innovation should focus on integrating AI with wearable technologies, developing comprehensive AI models for patient-specific predictions, and exploring unsupervised learning methods to handle unstructured data effectively. The nature of the market is competitive and rapidly evolving, with significant investment from both established healthcare entities and tech startups. Companies should continuously monitor regulatory changes and technological advancements to stay ahead in this dynamic environment. By fostering innovation and strategic collaboration, businesses can not only overcome present limitations but also tap into emerging opportunities for robust growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Intelligence in Biomedical Market

The Artificial Intelligence in Biomedical Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing digitalization and research in the biomedical sector worldwide
  • Surge in drug discovery & development activities
  • Rising demand for personalized and customized medicine
• Market Restraints
  • High cost associated with AI in biomedical
• Market Opportunities
  • Technological advancements in AI in biomedical solutions
  • Favorable investment landscape for the development of AI in biomedical solutions
• Market Challenges
  • Concerns associated with data privacy and security

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Intelligence in Biomedical Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Intelligence in Biomedical Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Intelligence in Biomedical Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Intelligence in Biomedical Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Intelligence in Biomedical Market

A detailed market share analysis in the Artificial Intelligence in Biomedical Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Intelligence in Biomedical Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Intelligence in Biomedical Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Intelligence in Biomedical Market

A strategic analysis of the Artificial Intelligence in Biomedical Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Intelligence in Biomedical Market, highlighting leading vendors and their innovative profiles. These include AiCure, LLC, Arterys Inc., Aspen Technology Inc, Atomwise Inc, Augmedix, Inc., Behold.ai Technologies Limited, BenevolentAI SA, BioSymetrics Inc., BPGbio Inc., Butterfly Network, Inc., Caption Health, Inc. by GE Healthcare, Cloud Pharmaceuticals, Inc., CloudMedX Inc., Corti ApS, Cyclica Inc, Deargen Inc, Deep Genomics Incorporated, Euretos Services BV, Exscientia plc, Google, LLC by Alphabet, Inc., Insilico Medicine, Intel Corporation, International Business Machines Corporation, InveniAI LLC, Isomorphic Labs, Novo Nordisk A/S, Sanofi SA, Turbine Ltd., Viseven Europe OU, and XtalPi Inc..

Market Segmentation & Coverage

This research report categorizes the Artificial Intelligence in Biomedical Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Components, market is studied across Hardware, Services, and Software.
• Based on Technology, market is studied across Computer Vision, Context-Aware Computing, Machine Learning, Natural Language Processing, and Querying Method.
• Based on Application, market is studied across Clinical Decision Support, Clinical Trial Coordinators & Investigators, Drug Discovery & Development, Genomics & Personalized Medicine, and Medical Imaging & Radiology.
• Based on End-Users, market is studied across Biotechnology Firms, Hospitals & Diagnostic Centers, Pharmaceutical Companies, and Research Institutions.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing digitalization and research in the biomedical sector worldwide
    • 5.1.1.2. Surge in drug discovery & development activities
    • 5.1.1.3. Rising demand for personalized and customized medicine
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with AI in biomedical
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in AI in biomedical solutions
    • 5.1.3.2. Favorable investment landscape for the development of AI in biomedical solutions
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns associated with data privacy and security
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Significant penetration of AI-based biomedical software
  • 5.2.2. Application: Extensive use in drug discovery & development
  • 5.2.3. End-Users: Expanding applications of AI-based biomedical solutions in pharmaceutical companies
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Artificial Intelligence in Biomedical Market, by Components

• 6.1. Introduction
• 6.2. Hardware
• 6.3. Services
• 6.4. Software

7. Artificial Intelligence in Biomedical Market, by Technology

• 7.1. Introduction
• 7.2. Computer Vision
• 7.3. Context-Aware Computing
• 7.4. Machine Learning
• 7.5. Natural Language Processing
• 7.6. Querying Method

8. Artificial Intelligence in Biomedical Market, by Application

• 8.1. Introduction
• 8.2. Clinical Decision Support
• 8.3. Clinical Trial Coordinators & Investigators
• 8.4. Drug Discovery & Development
• 8.5. Genomics & Personalized Medicine
• 8.6. Medical Imaging & Radiology

9. Artificial Intelligence in Biomedical Market, by End-Users

• 9.1. Introduction
• 9.2. Biotechnology Firms
• 9.3. Hospitals & Diagnostic Centers
• 9.4. Pharmaceutical Companies
• 9.5. Research Institutions

10. Americas Artificial Intelligence in Biomedical Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Artificial Intelligence in Biomedical Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Artificial Intelligence in Biomedical Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Bionl.AI Launches Innovative Platform for No-Code Biomedical Research
  • 13.3.2. Epistemic AI launches biomedical GPT at BIO
  • 13.3.3. NIH launches Bridge2AI program to expand the use of artificial intelligence in biomedical and behavioral research
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AiCure, LLC
• 2. Arterys Inc.
• 3. Aspen Technology Inc
• 4. Atomwise Inc
• 5. Augmedix, Inc.
• 6. Behold.ai Technologies Limited
• 7. BenevolentAI SA
• 8. BioSymetrics Inc.
• 9. BPGbio Inc.
• 10. Butterfly Network, Inc.
• 11. Caption Health, Inc. by GE Healthcare
• 12. Cloud Pharmaceuticals, Inc.
• 13. CloudMedX Inc.
• 14. Corti ApS
• 15. Cyclica Inc
• 16. Deargen Inc
• 17. Deep Genomics Incorporated
• 18. Euretos Services BV
• 19. Exscientia plc
• 20. Google, LLC by Alphabet, Inc.
• 21. Insilico Medicine
• 22. Intel Corporation
• 23. International Business Machines Corporation
• 24. InveniAI LLC
• 25. Isomorphic Labs
• 26. Novo Nordisk A/S
• 27. Sanofi SA
• 28. Turbine Ltd.
• 29. Viseven Europe OU
• 30. XtalPi Inc.

LIST OF FIGURES

• FIGURE 1. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET RESEARCH PROCESS
• FIGURE 2. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET DYNAMICS
• TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY CONTEXT-AWARE COMPUTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY QUERYING METHOD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY CLINICAL DECISION SUPPORT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY CLINICAL TRIAL COORDINATORS & INVESTIGATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY MEDICAL IMAGING & RADIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 41. CANADA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 42. CANADA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 43. CANADA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. CANADA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. AUSTRALIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 63. CHINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 64. CHINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. CHINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. CHINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 67. INDIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 68. INDIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. INDIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. INDIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 72. INDONESIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. INDONESIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. INDONESIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 76. JAPAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 77. JAPAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. JAPAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 80. MALAYSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. MALAYSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. MALAYSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 84. PHILIPPINES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. PHILIPPINES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. PHILIPPINES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 88. SINGAPORE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. SINGAPORE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SINGAPORE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 96. TAIWAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. TAIWAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. TAIWAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 100. THAILAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. THAILAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. THAILAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 104. VIETNAM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 105. VIETNAM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. VIETNAM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 111. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 113. DENMARK ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 114. DENMARK ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. DENMARK ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 117. EGYPT ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. EGYPT ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. EGYPT ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 121. FINLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. FINLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. FINLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 125. FRANCE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 126. FRANCE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. FRANCE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 129. GERMANY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 130. GERMANY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. GERMANY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 133. ISRAEL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 134. ISRAEL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. ISRAEL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 136. ITALY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 137. ITALY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 138. ITALY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. ITALY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 141. NETHERLANDS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 142. NETHERLANDS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. NETHERLANDS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 145. NIGERIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 146. NIGERIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. NIGERIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 149. NORWAY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 150. NORWAY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. NORWAY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 152. POLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 153. POLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 154. POLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. POLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 156. QATAR ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 157. QATAR ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 158. QATAR ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. QATAR ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 161. RUSSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 162. RUSSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. RUSSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 165. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 166. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 173. SPAIN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 174. SPAIN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. SPAIN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 177. SWEDEN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 178. SWEDEN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. SWEDEN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 181. SWITZERLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 182. SWITZERLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. SWITZERLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 185. TURKEY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 186. TURKEY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. TURKEY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 190. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 194. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 196. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 197. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET, FPNV POSITIONING MATRIX, 2023